• Bintrafusp alfa (also known as M7824 and MSB0011359C) is an investigational, bifunctional immunotherapy designed to simultaneously block PD-L1 and TGF-β, two immuno-inhibitory pathways that are commonly used by cancer cells to evade the immune system